Aarti Drugs quarterly results and financials

Aarti Drugs (AARTIDRUGS)₹499.75+11.08%(9 Nov 2026 close)Pharmaceuticals

Key facts

In the Jun 2026 quarter (consolidated), Aarti Drugs reported sales of ₹702 Cr, up 18.9% from Jun 2025, and net profit of ₹49.81 Cr, down 7.5% year on year. For the year to Mar 2026, sales were ₹2,564 Cr and net profit ₹194 Cr.

Sales (Jun 2026): ₹702 Cr
Net profit (Jun 2026): ₹49.81 Cr
Sales (FY Mar 2026): ₹2,564 Cr
Net profit (FY Mar 2026): ₹194 Cr
EPS (Jun 2026): ₹5.48
Borrowings (Mar 2026): ₹576 Cr

Company filings, consolidated accounts; latest reported quarter Jun 2026

Aarti Drugs quarterly results

₹ crore unless stated; each column is a quarter.

Aarti Drugs Quarterly results
	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	642	605	620	555	598	556	677	591	653	602	720	702
Expenses	563	534	532	488	529	493	581	514	567	545	621	603
Operating Profit	76.11	70.14	86.16	65.11	67.15	62.17	93.14	74.17	84.17	55.15	96.14	98.25
OPM %	11.9%	12.0%	14.0%	11.9%	11.0%	11.0%	13.9%	12.9%	13.0%	9.0%	12.9%	13.9%
Other Income	0.99	1.99	0.99	0.99	0.99	11.96	1.99	0.00	0.00	0.99	0.99	−0.99
Interest	7.99	7.99	8.99	8.99	8.98	8.98	8.99	8.99	7.98	8.98	7.99	8.98
Depreciation	12.99	12.99	13.99	12.98	14.01	13.98	14.99	14.99	15.99	17.99	17.98	18.01
Profit before tax	56.01	51.98	63.94	43.99	45.96	50.99	70.93	50.99	60.01	28.99	70.01	69.02
Tax %	30.1%	29.1%	26.1%	24.1%	24.1%	27.1%	12.1%	−6.0%	25.1%	−39.9%	21.1%	28.1%
Exceptional items	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	−1.99
Net Profit	39.88	36.91	46.84	32.89	34.90	36.90	62.81	53.82	44.85	40.88	54.80	49.81
EPS (Rs)	4.29	3.97	5.13	3.61	3.83	4.04	6.86	5.89	4.94	4.42	6.02	5.48

Aarti Drugs profit and loss

₹ crore unless stated; years end in March. TTM is the last four quarters.

Aarti Drugs Profit and loss
	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	1,140	1,194	1,243	1,559	1,806	2,152	2,487	2,714	2,527	2,385	2,564	2,676
Expenses	956	1,000	1,038	1,345	1,536	1,708	2,147	2,399	2,199	2,090	2,247	2,336
Operating Profit	180	190	202	212	266	441	333	309	322	290	309	334
OPM %	16.0%	15.9%	16.0%	13.9%	15.0%	20.0%	13.0%	10.9%	13.0%	11.9%	11.9%	12.5%
Other Income	0.00	3.98	0.99	5.97	5.98	4.98	10.95	1.99	3.98	15.93	1.99	0.99
Interest	47.89	39.95	37.94	43.92	36.94	25.96	23.98	36.92	37.94	38.95	33.97	33.93
Depreciation	36.99	37.98	39.95	43.01	48.95	49.99	50.01	49.95	50.98	55.98	66.92	69.97
Profit before tax	94.99	116	125	131	185	369	270	224	236	212	211	228
Tax %	28.1%	29.1%	34.1%	32.1%	24.1%	24.1%	24.1%	26.1%	27.1%	21.1%	8.1%	—
Exceptional items	0.00	0.99	0.00	2.99	2.99	0.00	0.00	0.00	0.00	0.00	0.00	−1.99
Net Profit	68.76	81.79	81.73	89.75	141	279	204	166	171	168	194	190
EPS (Rs)	7.06	8.54	8.69	9.48	15.10	29.97	22.06	17.88	18.58	18.35	21.27	20.86
Dividend payout %	23.9%	3.0%	3.0%	3.0%	3.0%	8.0%	5.0%	6.0%	5.0%	5.0%	9.0%	—

Aarti Drugs balance sheet

₹ crore, at each year end.

Aarti Drugs Balance sheet
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	24.01	24.02	24.01	24.02	24.02	23.02	92.98	92.99	93.05	91.99	91.04	91.07
Reserves	284	333	376	433	521	630	821	945	1,100	1,191	1,279	1,460
Borrowings	448	482	479	546	507	389	351	542	609	564	614	576
Other Liabilities	248	262	310	388	404	535	501	629	619	587	591	690
Total Liabilities	1,004	1,102	1,190	1,389	1,454	1,576	1,766	2,209	2,420	2,433	2,575	2,816
Fixed Assets	447	493	580	601	624	644	664	689	675	810	866	1,085
CWIP	16.02	34.03	14.01	28.02	33.06	12.01	19.02	77.14	210	261	330	214
Investments	5.02	5.02	12.05	11.03	12.04	13.06	17.06	19.06	19.07	20.08	22.06	27.08
Other Assets	534	570	584	749	785	907	1,064	1,423	1,516	1,341	1,356	1,490
Inventories	167	178	211	279	248	326	416	527	518	487	474	493
Trade receivables	314	332	297	375	459	489	555	748	864	704	749	828
Cash & equivalents	3.98	4.98	3.99	3.99	5.98	7.97	9.97	21.91	8.96	8.97	7.97	8.97
Total Assets	1,004	1,102	1,190	1,389	1,454	1,576	1,766	2,209	2,420	2,433	2,575	2,816

Aarti Drugs cash flow

₹ crore, for each year.

Aarti Drugs Cash flow
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from operating activity	105	133	175	69.98	143	251	155	70.02	133	359	245	254
Cash from investing activity	−107	−99.15	−107	−74.10	−62.09	−33.03	−72.10	−150	−164	−224	−165	−173
Cash from financing activity	0.99	−32.96	−67.85	3.99	−79.82	−215	−80.84	91.85	16.98	−136	−81.87	−76.82
Net cash flow	−0.99	0.99	0.00	0.00	1.01	1.99	2.01	13.01	−14.02	−1.01	−2.01	3.01
Capex	107	100	109	75.26	74.25	48.17	88.35	153	166	227	178	173
Free cash flow	−2.01	34.08	68.08	−5.01	80.18	214	78.09	−82.15	−31.04	133	67.17	80.10
CFO / OP %	68.9%	84.9%	102.9%	47.0%	82.0%	109.9%	56.9%	45.9%	61.9%	131.0%	102.9%	80.9%

Aarti Drugs ratios

Working-capital days and returns, by year.

Aarti Drugs Ratios
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor days	105	106	91	110	107	99	94	110	116	102	115	118
Inventory days	83	87	101	133	87	103	118	116	102	108	115	112
Days payable	83	90	94	123	85	104	93	103	94	94	100	108
Cash conversion cycle	104	103	97	119	109	97	118	123	123	115	129	121
Working capital days	15	20	23	34	45	55	78	64	73	75	77	77
ROCE %	—	18.0%	18.1%	17.0%	17.1%	21.0%	34.0%	21.1%	15.0%	15.0%	13.0%	12.1%

Aarti Drugs: frequently asked questions

What are the latest quarterly results of Aarti Drugs?

For the Jun 2026 quarter, Aarti Drugs reported sales of ₹702 Cr, up 18.9% year on year and net profit of ₹49.81 Cr, down 7.5% year on year. The operating margin was 13.9%.

What is the annual revenue of Aarti Drugs?

Aarti Drugs' sales for the year to Mar 2026 were ₹2,564 Cr; over the last twelve months they were ₹2,676 Cr.

What is the net profit of Aarti Drugs?

Net profit for the year to Mar 2026 was ₹194 Cr, and ₹190 Cr over the last twelve months. Earnings per share over the same trailing period were ₹20.86.

How much debt does Aarti Drugs have?

Aarti Drugs reported borrowings of ₹576 Cr at Mar 2026, against cash and equivalents of ₹8.97 Cr.

What is the free cash flow of Aarti Drugs?

Cash from operations was ₹254 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹80.10 Cr.

Loading…